The Effectiveness of FRAME FR for AVF Repair in High-Flow Reduction &

Status Active, not recruiting

Clinical Trial Summary

Patients with end-stage renal disease require permanent vascular access to enable safe and effective hemodialysis. An arteriovenous fistula (AVF), where a vein is mobilized and connected to an artery in the arm, is considered the gold standard and first choice for vascular access. After fistula creation, the vein is subjected to high pressure and flow, and undergoes remodeling. This includes the possibility of significant dilatation and intimal hyperplasia. Normal AVF flow required for effective dialysis is around 0.6 liters/min or 0.4-0.8 liters/min. However, in at least 20% of patients, excessive remodeling and dilatation of the fistula result in a high flow AVF with >2 liters/min. High flow fistulas significantly increase the risk for the development of high output cardiac failure, skin breakdown, bleeding, hand ischemia, and other systemic complications. In cases of high flow AVF, venous reconstruction procedures, banding and/or plication, are often required to limit venous diameter and flow. The longevity of this procedure is limited as the reconstructed segment remodels and re-dilates due to ongoing arterial pressure. Banding and plication are both procedures that are designed to increase resistance to flow. Banding is performed by wrapping a segment of polytetrafluoroethylene (PTFE) around the outflow tract of the fistula, or by placing a suture around the fistula near the arterial anastomotic area to create a narrowing. Fistula plication involves narrowing of a short segment of the proximal venous outflow tract, usually accomplished by suturing or stapling the fistula for 2-6 cm. One of the notable systemic effects of a hemodialysis AVF is an acute decrease in systemic vascular resistance with a simultaneous increase in venous return to the heart, and thus an increase of the cardiac output. Cardiac failure occurs more frequently in patients with an access flow QA>2 l/min and CPR≥20%. Another adverse systemic effect of AV fistulas is pulmonary hypertension. The increased flow volume to the heart from an AV fistula yields an increase in pulmonary pressures. This can limit pulmonary vasodilation and result in pulmonary hypertension.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04795401
Study type	Interventional
Source	Fondation Hôpital Saint-Joseph
Contact
Status	Active, not recruiting
Phase	N/A
Start date	April 6, 2021
Completion date	April 5, 2024

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05302505` - Simulation-based Training for Nurses and Arteriovenous Fistula Puncture in Chronic Hemodialysis Patients	N/A
Terminated	`NCT01642459` - The Outcomes of Arteriovenous Fistula Cannulated From Different Direction.	N/A
Recruiting	`NCT04017806` - Investigating the Role of Luminal Pressure on Arteriovenous Fistula Maturation
Terminated	`NCT03668002` - Trial of Fistula Versus Graft in Elderly Patients	N/A
Completed	`NCT06199609` - Changes in Cardiac Structure and Function After Establishment of Autologous Arteriovenous Fistula
Recruiting	`NCT04034433` - Exercise Program for Arteriovenous Fistula Maturation	N/A
Active, not recruiting	`NCT04629118` - Intervention With Selution SLR™ Agent Balloon for Endovascular Latent Limus Therapy for Failing AV Fistulas (ISABELLA) Trial
Recruiting	`NCT02913365` - Etiologies, Investigations and Outcomes of Patients Presenting With Hemoptysis	N/A
Recruiting	`NCT05616104` - FLEX FIRST Registry Research Protocol
Recruiting	`NCT03886116` - Effect of Pre-operative Forearm Exercises on Arterial Venous Fistula Maturation and Blood Flow	N/A
Completed	`NCT02513303` - Trial to Evaluate the Sirolimus-Eluting Collagen Implant on AV Fistula Outcomes	Phase 3
Completed	`NCT01863914` - Vascular Protective Effect of Rosuvastatin in Arteriovenous Fistula	Phase 2
Recruiting	`NCT06001827` - SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study	N/A
Recruiting	`NCT04543539` - IN.PACT™ AV Access Post-Approval Study (PAS002)
Completed	`NCT05326321` - Effect of Virtual Reality Glasses in The Arteriovenous Fistule Cannulation Processon Paın and Patient Satisfaction	N/A
Recruiting	`NCT03741985` - Effect of Dumbbell Exercise on Arteriovenous Fistula in Patients With Hemodialysis	N/A
Terminated	`NCT03566927` - FLEX®-DCB Dialysis ACCESS Stenosis Study	N/A
Not yet recruiting	`NCT04393688` - Study Evaluating the Safety and Efficacy of Tri-wire Balloon for Treatment of Dysfunctional AV Fistula	N/A
Recruiting	`NCT02447796` - Dexmedetomidine and Propofol As Sole Sedative Agent for Patients Undergoing Arteriovenous Fistula Surgery	Phase 4
Terminated	`NCT01321866` - Cutting Balloon Versus Non-cutting Balloon for the Treatment of Venous Stenosis in the Fistulas of Hemodialyzed Patients	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

The Effectiveness of FRAME FR for AVF Repair in High-Flow Reduction & Stabilization, A Prospective Trial — FRAME

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms